The trademark application GAVRETO was filed by Blueprint Medicines Corporation, a U.S. corporation (the "Applicant"). The application was published for oppositions on July 15, 2020, and it was registered by office on October 23, 2020 without any oppositions.
The application was filed in English (French was selected as the second language).